ABSTRACT
Analysis of immunomodulation by intravenous immunoglobulin (IVIG) at the clinical level is simple, involving observation of straightforward clinical parameters. At a molecular level, it is more difficult to discern the ways in which molecules and processes are significantly, consistently and reliably perturbed by infusion of the molecular mean of >20 000 allogeneic extracellular fluid proteomes.
